Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report

Biotech giant Amgen (AMGN) could be nearing a deal to buy Alexion Pharmaceuticals (ALXN) at a 74% premium, according to a Spanish news outlet.

Late Wednesday, Intereconomia.com reported Amgen is "in the final stretch to buy Alexion" for $200 per share, Mizuho Securities analyst Salim Syed said in a report. Intereconomia.com cited people familiar with the matter.